Released Feb 24, 2020, after the close
10-K filed Feb 24, 2020, 55 days after period end · 0001564590-20-006037
Q4 2019 · 10-K
Revenue$121.49M$121.49M +0.3% vs Q4 2018+7.0% vs Q3 2019
Net Income$11.69M$11.69M +31.7% vs Q4 2018N/M vs Q3 2019
EPS Diluted$0.60$0.60 +30.4% vs Q4 2018N/M vs Q3 2019
Gross Profit$95,303,000−0.2%
Operating Income$4,095,000−67.0%
Operating Cash Flowderived$11,943,000−43.4%
Free Cash Flowderived$6,683,000−60.9%
Margins · derived
Gross margin78.4%−0.4 pt vs Q4 2018
Operating margin3.4%−6.9 pt vs Q4 2018
Net margin9.6%+2.3 pt vs Q4 2018
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2019 | Q4 2018 | Q4 2017 | Q4 2016 |
|---|---|---|---|---|
| Revenue | $121.49M | $121.08M | $116.90M | $108.54M |
| Net Income | $11.69M | $8.87M | $1.57M | -$3.24M |
| EPS Diluted | $0.60 | $0.46 | $0.08 | -$0.18 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR